Amorepacific Showcases AI Innovations in Skincare at IFSCC Congress
Amorepacific presented AI-driven skincare innovations at the IFSCC Congress 2025, including virtual makeup and skin prediction algorithms, according to a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Amorepacific presented AI-driven skincare innovations at the IFSCC Congress 2025, including virtual makeup and skin prediction algorithms, according to a press release.
TransMedics Group, Inc. has announced a collaboration with Mercedes-Benz Group AG to establish a dedicated organ transportation network in Italy, utilizing Mercedes-Benz V-class vehicles.
Trinity Capital has committed $45 million in growth capital to Rapid Micro Biosystems to support its automation solutions in healthcare manufacturing.
States of Mind has launched a new platform to improve access to advanced mental health treatments across Europe, announced in a press release.
Stellarus has announced that Hawaii Medical Service Association and Blue Cross and Blue Shield of Kansas have joined its AI-powered healthcare platform to enhance member experiences and health outcomes.
Moberg Analytics has introduced the Moberg Clinical Platform (MCP), an AI-driven system for brain injury monitoring, announced in a press release.
Stanford Medicine has introduced CRISPR-GPT, an AI tool designed to streamline gene-editing experiments, potentially speeding up drug development.
Lila Sciences has raised $235 million to enhance its AI-driven research capabilities, aiming to accelerate scientific discovery through autonomous laboratories.
Gyala Therapeutics has announced preclinical results demonstrating the efficacy of its CAR-T therapy, GYA01, targeting the CD84 protein in leukemia.
ARTHEx Biotech has successfully closed an upsized Series B financing round, raising $87 million to advance its lead program ATX-01 for Myotonic Dystrophy Type 1.
Senhwa Biosciences has announced a collaboration with Sanofi and Regeneron Pharmaceuticals to evaluate its drug Pidnarulex in combination with Cemiplimab for colorectal cancer treatment.
Mount Sinai Fuster Heart Hospital has launched the Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab to enhance interventional cardiology through AI.
ProofPilot has acquired Lokavant to integrate predictive analytics into its clinical trial platform, enhancing trial execution and data insights.
University Lab Partners and BARDA have announced the ReadyDetect competition, offering $10 million to advance next-generation diagnostics for detecting key pathogens.
PhaseV will showcase its AI/ML advancements for clinical trials at upcoming biopharma events, highlighting their impact on trial efficiency and success.
p36 GmbH has introduced UDI Connect, a SaaS solution aimed at automating compliance processes for medical device companies, as announced in a press release.
BEVIMI, a new brain health and wellness company, was launched at the CG Well Summit, focusing on cognitive longevity through AI-driven solutions.
Armor Health has announced a partnership with Antidote-AI to integrate AI clinical tools into its Insights Analytics platform, enhancing healthcare in correctional facilities.
MGI Tech Co., Ltd. has launched the DNBSEQ-T7+, a high-throughput sequencer designed for large-scale genomic research, offering over 14 terabases of data per day.
Cardinality.ai has launched CardyCares, an AI-powered suite designed to modernize Medicaid Enterprise Systems, as announced in a press release. The suite aims to automate routine tasks and improve healthcare outcomes.